checkAd

     148  0 Kommentare Crinetics Pharmaceuticals Announces Pricing of Public Offering of Common Stock - Seite 3

    Contacts:
    Marc Wilson
    Chief Financial Officer
    IR@crinetics.com
    (858) 450-6464

    Lesen Sie auch

    Robert H. Uhl
    Westwicke ICR
    robert.uhl@westwicke.com
    (858) 356-5932


    globenewswire
    0 Follower
    Autor folgen
    Seite 3 von 3

    Verfasst von globenewswire
    Crinetics Pharmaceuticals Announces Pricing of Public Offering of Common Stock - Seite 3 SAN DIEGO, April 15, 2020 (GLOBE NEWSWIRE) - Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and …

    Schreibe Deinen Kommentar

    Disclaimer